Vimarsana
Biggest News Aggregation in the World

Chris Neyor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris Neyor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Neyor Today - Breaking & Trending Today

Oyster Point Pharma, Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Oyster Point Pharma, Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript

Published: May 8, 2022

Oyster Point Pharma, Inc. (NASDAQ:NASDAQ:OYST) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Arty Ahmed - Vice President, Investor Relations Dr.

Source: seekingalpha.com
Related Topics:
United StatesJi XingPatrick DolezalChris NeyorCory JubinvilleDan LochnerJohn SnisarenkoOyster Point Pharma IncCompany ParticipantsScripts NationalJi Xing PharmaceuticalsUnitedhealth GroupOyster Point PharmaConference Call MayJeffrey NauFirst QuarterParty AhmedChief Executive OfficerChief Financial OfficerChief CommercialChief ExecutiveOyster PointChief Commercial OfficerExpress Scripts National PreferredKen Cacciatore
Oyster Point Pharma, Inc. (OYST) Q1 2022 Earnings Call Transcript - Vimarsana News

Oyster Point Pharma, Inc. (OYST) Q1 2022 Earnings Call Transcript

Published: May 6, 2022

OYST earnings call for the period ending March 31, 2022.

Source: fool.com
Related Topics:
United StatesJi XingPatrick DolezalChris NeyorCory Jubinville LifesciDan LochnerJohn SnisarenkoOyster Point Pharma IncScripts NationalJi Xing PharmaceuticalsCompany AnalystUnitedhealth GroupOyster Point PharmaTyrvaya NasalJeffrey NauChief ExecutiveNasal SprayOyster PointTyrvaya Nasal SprayExpress Scripts National PreferredKen CacciatoreSci Capital
Oyster Point Pharma, Inc. (OYST) Q4 2021 Earnings Call Transcript - Vimarsana News

Oyster Point Pharma, Inc. (OYST) Q4 2021 Earnings Call Transcript

Published: February 25, 2022

OYST earnings call for the period ending December 31, 2021.

Source: fool.com
Related Topics:
United StatesJi XingChris NeyorJoe CatanzaroPiper SandlerDan LochnerJohn SnisarenkoPatrick Dolezal LifesciPatrick DolezalJoe Catanzaro Piper SandlerDaniel LochnerScripts NationalOyster Point Pharma IncJi Xing PharmaceuticalsCompany AnalystOyster Point PharmaJeffrey NauOyster PointChief ExecutiveGreater ChinaExpress ScriptsAdaptive PhageExpress Scripts National PreferredHigh Performance FormulariesNew Drug Application
Repros Therapeutics (RPRX) Q1 2021 Earnings Call Transcript - Vimarsana News

Repros Therapeutics (RPRX) Q1 2021 Earnings Call Transcript

Published: May 12, 2021

RPRX earnings call for the period ending March 31, 2021.

Source: fool.com
Related Topics:
United StatesChris NeyorGreg GilbertAmerica Merrill LynchGreg Gilbert TruistChristopher SchottGeorge GrofikTerence Flynn Goldman SachsJim ReddochTerry CoynePablo LegorretaChris SchottTerence FlynnRoche EvrysdiMarshall UristGeoff MeachamHead Of ResearchGoldman SachsGeoff Meacham BankJp MorganCompany AnalystRepros TherapeuticsRoyalty PharmaVice PresidentInvestor Relations